[PHARMA] YoY Annualized Quarter Result on 31-Mar-2012 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
03-May-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
31-Mar-2012 [#1]
Profit Trend
QoQ- 119.99%
YoY- 85.26%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 CAGR
Revenue 1,887,616 1,874,688 2,001,356 1,786,980 1,541,312 1,270,240 1,254,864 7.03%
PBT 154,448 152,636 147,696 171,820 87,168 49,724 80,736 11.41%
Tax -26,744 -46,052 -47,084 -55,576 -24,772 -12,488 -21,964 3.33%
NP 127,704 106,584 100,612 116,244 62,396 37,236 58,772 13.80%
-
NP to SH 127,176 104,868 99,084 114,740 61,936 37,228 58,088 13.94%
-
Tax Rate 17.32% 30.17% 31.88% 32.35% 28.42% 25.11% 27.20% -
Total Cost 1,759,912 1,768,104 1,900,744 1,670,736 1,478,916 1,233,004 1,196,092 6.64%
-
Net Worth 528,173 515,022 484,829 474,161 437,661 439,675 402,378 4.63%
Dividend
31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 CAGR
Div 72,494 41,408 35,303 35,297 - - - -
Div Payout % 57.00% 39.49% 35.63% 30.76% - - - -
Equity
31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 CAGR
Net Worth 528,173 515,022 484,829 474,161 437,661 439,675 402,378 4.63%
NOSH 258,908 258,805 117,676 117,657 107,007 106,977 107,015 15.85%
Ratio Analysis
31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 CAGR
NP Margin 6.77% 5.69% 5.03% 6.51% 4.05% 2.93% 4.68% -
ROE 24.08% 20.36% 20.44% 24.20% 14.15% 8.47% 14.44% -
Per Share
31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 CAGR
RPS 729.07 724.36 1,700.72 1,518.79 1,440.38 1,187.40 1,172.60 -7.61%
EPS 49.12 40.52 84.20 97.52 57.88 34.80 54.28 -1.65%
DPS 28.00 16.00 30.00 30.00 0.00 0.00 0.00 -
NAPS 2.04 1.99 4.12 4.03 4.09 4.11 3.76 -9.68%
Adjusted Per Share Value based on latest NOSH - 117,657
31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 CAGR
RPS 130.97 130.07 138.86 123.99 106.94 88.13 87.07 7.03%
EPS 8.82 7.28 6.87 7.96 4.30 2.58 4.03 13.93%
DPS 5.03 2.87 2.45 2.45 0.00 0.00 0.00 -
NAPS 0.3665 0.3573 0.3364 0.329 0.3037 0.3051 0.2792 4.63%
Price Multiplier on Financial Quarter End Date
31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 CAGR
Date 31/03/15 31/03/14 29/03/13 30/03/12 31/03/11 31/03/10 31/03/09 -
Price 6.00 4.46 8.26 5.90 5.73 4.27 3.45 -
P/RPS 0.82 0.62 0.49 0.39 0.40 0.36 0.29 18.90%
P/EPS 12.21 11.01 9.81 6.05 9.90 12.27 6.36 11.47%
EY 8.19 9.09 10.19 16.53 10.10 8.15 15.73 -10.30%
DY 4.67 3.59 3.63 5.08 0.00 0.00 0.00 -
P/NAPS 2.94 2.24 2.00 1.46 1.40 1.04 0.92 21.35%
Price Multiplier on Announcement Date
31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 CAGR
Date 18/05/15 14/05/14 15/05/13 03/05/12 13/05/11 26/05/10 08/05/09 -
Price 6.91 4.70 9.26 5.90 5.05 4.71 3.82 -
P/RPS 0.95 0.65 0.54 0.39 0.35 0.40 0.33 19.26%
P/EPS 14.07 11.60 11.00 6.05 8.72 13.53 7.04 12.22%
EY 7.11 8.62 9.09 16.53 11.46 7.39 14.21 -10.89%
DY 4.05 3.40 3.24 5.08 0.00 0.00 0.00 -
P/NAPS 3.39 2.36 2.25 1.46 1.23 1.15 1.02 22.15%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment